Navigation Links
ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO

2/3 clinical trials for chronic myeloid leukemia (CML) and Quinamed(R) is in phase 2 clinical development for prostate, breast and ovarian cancers. The company has a significant portfolio of anti-cancer, diabetes and obesity programs, several of which have been partnered with international pharmaceutical companies. ChemGenex currently trades on the Australian Stock Exchange under the symbol "CXS" and on NASDAQ under the symbol "CXSP".

Safe Harbor Statement

Certain statements made herein that use the words "estimate", "project", "intend", "expect", "believe", and similar expressions are intended to identify forward-looking statements within the meaning of the US Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks and uncertainties which could cause the actual results, performance or achievements of the company to be materially different from those which may be expressed or implied by such statements, including, among others, risks or uncertainties associated with the development of the company's technology, the ability to successfully market products in the clinical pipeline, the ability to advance promising therapeutics through clinical trials, the ability to establish our fully integrated technologies, the ability to enter into additional collaborations and strategic alliances and expand current collaborations and obtain milestone payments, the suitability of internally discovered genes for drug development, the ability of the company to meet its financial requirements, the ability of the company to protect its proprietary technology, potential limitations on the company's technology, the market for the company's products, government regulation in Australia and the United States, changes in tax and other laws, changes in competition and the loss of key personnel. These statements are based on our management's current expectations and are subject to a number of uncertainties that could chan
'"/>




Page: 1 2 3 4

Related medicine technology :

1. ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
2. Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex
3. Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex
4. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
5. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
6. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
7. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
8. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
9. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
10. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
11. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
Post Your Comments:
(Date:7/31/2014)... 31, 2014  A substantial share of pharmacy ... which therapies are included in formularies—say patient support ... a new Manhattan Research study, Taking the ... finds that P&T committee members in hospitals, managed ... have set a high bar for these programs, ...
(Date:7/31/2014)... , July 31, 2014 Catylix, ... Aspira Scientific ( Milpitas, California ) ... to develop and commercialize new fluorination products and ... molecules has benefited from the use of substituents ... combine lipophilicity with polarity to improve binding and ...
(Date:7/31/2014)... Ariz. , July 31, 2014 For ... public can watch the implantation of the SynCardia temporary ... paper and matching video posted on the Journal of ... video and read the paper on the SynCardia Total ... The 16-minute video accompanies "Implantation of the SynCardia Total ...
Breaking Medicine Technology:Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 2Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 3Catylix, Inc. and Aspira Scientific Announce Joint Venture to Commercialize New Fluorination Technologies 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 3
... Md. , May 6 The U.S. Food and Drug Administration ... , , , ... , , ... (estradiol valerate) and a progestin (dienogest), and is the first four-phasic oral contraceptive ...
... An innovative catheter-based procedure is providing relief to patients who suffer ... severely leaky heart valve, but who are too sick for open-chest surgery, ... and Interventions (SCAI) 33rd Annual Scientific Sessions. , ... Data from the Endovascular Valve Edge-to-Edge REpair STudy ...
Cached Medicine Technology:FDA Approves New Combination Product Oral Contraceptive 2MitraClip Safely Relieves Symptoms in Patients With No Surgical Options 2MitraClip Safely Relieves Symptoms in Patients With No Surgical Options 3MitraClip Safely Relieves Symptoms in Patients With No Surgical Options 4
(Date:7/31/2014)... Peninsula, MI (PRWEB) July 31, 2014 The ... preparation of the upcoming harvest. And, to celebrate, folks are ... Saturday and Sunday, September 6 and 7, 2014 along the ... festivities is an optional walk or run through the vineyards ... Winery in Suttons Bay. A unique course between rows of ...
(Date:7/31/2014)... Jeremiah’s Tavern joins other ... create a unique atmosphere and highlight their commitment ... reclaimed barn siding on the exterior façade ... flowing throughout the interior as flooring. In addition, ... New Energy Works Timberframers add atmosphere ...
(Date:7/31/2014)... York, NY (PRWEB) July 31, 2014 ... works to open the airway and provide an easier ... jaw. The end results are that people can breathe ... The device is entirely adjustable so that it can ... It's effectiveness for snorers is often shared by actual ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 July 31, 2014- ... 18th. To celebrate they have launched a Facebook Sweepstakes giving ... enter all you have to do is visit http://www.facebook.com/titleboxingcoolsprings ... you enter, share with your friends, and for each one ... , “We are so excited to bring such a ...
(Date:7/31/2014)... Parker Waichman, LLP, a national law ... that whistleblowers are a critical component of the process ... may cause harm to consumers and may defraud the ... Day. , According to a 2013 report issued by ... "National Whistleblower Appreciation Day" on July 30, 2013; the ...
Breaking Medicine News(10 mins):Health News:Leelanau Peninsula’s Annual Harvest Stompede Offers a Unique Vineyard Course for Walkers, Runners and Wine Tasters 2Health News:Popular Tavern Restaurant Features Pioneer Millworks’ Reclaimed Wood in New Locations 2Health News:New Dental Device Reviews to Stop Snoring by VitalSleep 2Health News:National Whistleblower Appreciation Day Declared to Ensure Recognition of Enormous Contribution to the Democracy by Whistleblowers, Parker Waichman LLP Comments 2Health News:National Whistleblower Appreciation Day Declared to Ensure Recognition of Enormous Contribution to the Democracy by Whistleblowers, Parker Waichman LLP Comments 3Health News:National Whistleblower Appreciation Day Declared to Ensure Recognition of Enormous Contribution to the Democracy by Whistleblowers, Parker Waichman LLP Comments 4
... 15 Sedgwick Claims Management,Services, Inc. ... in its healthcare professional liability claims ... risk management and auditing.,Sedgwick CMS in ... other complex claims administration services for ...
... 15 Caris Diagnostics, a leading,provider of diagnostic ... the hiring of another nationally renowned,dermatopathologist for its ... Diagnostics to support the growing dermatopathology,practice for the ... in the dermatopathology community for,years, with his proven ...
... study shows they could protect against spread of disease ... used to treat people with HIV might also prevent ... researchers at the University of Texas Southwestern Medical Center ... infections worldwide, which total about 6,800 new transmissions daily, ...
... pulmonary fibrosis (IPF), an untreatable progressive lung disease that ... diagnosis, have a worse prognosis than non-smokers, according to ... that current smokers with IPF might live longer than ... likely reflected a healthy smoker effect. , The study ...
... 15 It,s time to think about fun ways,to get ... high school golf,circuit in southern California., (Photo: http://www.newscom.com/cgi-bin/prnh/20071220/AQTHFNS1 ... I am,constantly doing a variety of things that help me ... Here are some ideas to get you started:, ...
... Provides Migration Path for Healthcare Providers to New ... Electronic Health Card System in Germany, ... ), a leading provider of solutions that open the Digital,World, ... to be used as an MKT+ terminal (multi-functional,terminal) from GEMATIK, ...
Cached Medicine News:Health News:Sedgwick CMS Expands Healthcare Professional Liability Claims Services in Investigations, Risk Management, Audit & Consulting 2Health News:Sedgwick CMS Expands Healthcare Professional Liability Claims Services in Investigations, Risk Management, Audit & Consulting 3Health News:Caris Diagnostics Announces Addition of Leading Dermatopathologist to Expand Subspecialty Expertise 2Health News:Antiretroviral Drugs May Prevent Vaginal Transmission of HIV 2Health News:Smoking belies milder disease but worse prognosis for IPF patients 2Health News:10 Great Ways for Teens to Stay Fit - from One Teen to Another 2Health News:10 Great Ways for Teens to Stay Fit - from One Teen to Another 3Health News:e-Health Card Terminal From SCM Microsystems Receives GEMATIK Certification 2
... Traveler provides the ultimate flexibility for performing ... in the home, a patient room or ... utilize the same powerful Sleepscan VISION analysis ... studies take full advantage of many powerful ...
... in Digital EEG ,The company that ... presents the latest addition to the ... This innovative system incorporates the latest ... information management to offer you unprecedented ...
"Ganzfeld" stimulations for flash VEP, flash ERG and sensory EOG. Complies with international standards of electrophysiology....
The field of application of the SL 120 Slit Lamp extends from the anterior ocular segment and the vitreous right back to the fundus. It is the ideal configuration for observation, measurement, diagno...
Medicine Products: